Covered recipient · General Payments record
ANNA JUNE KEADY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$2,939.62
- Reported across 144 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $513.09 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.85 | 8 |
| Novo Nordisk AS | $112.34 | 6 |
| GlaxoSmithKline, LLC. | $60.06 | 3 |
| Mylan Specialty L.P. | $45.56 | 1 |
| Acerta Pharma LLC | $37.74 | 2 |
| MERZ NORTH AMERICA, INC. | $28.37 | 2 |
| Paratek Pharmaceuticals, Inc. | $19.67 | 1 |
| DEXCOM, INC. | $19.20 | 1 |
| Lilly USA, LLC | $16.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.40 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443233 | CMS |
| ABBVIE INC. | $21.02 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443235 | CMS |
| ABBVIE INC. | $21.59 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443237 | CMS |
| ABBVIE INC. | $18.96 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443239 | CMS |
| ABBVIE INC. | $25.36 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443241 | CMS |
| ABBVIE INC. | $32.34 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443243 | CMS |
| ABBVIE INC. | $28.25 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443245 | CMS |
| ABBVIE INC. | $17.93 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107443247 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.77 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104499136 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.97 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104211815 | CMS |
| Dexcom, Inc. | $19.20 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153349436 | CMS |
| GlaxoSmithKline, LLC. | $28.07 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116514433 | CMS |
| GlaxoSmithKline, LLC. | $14.74 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115864971 | CMS |
| GlaxoSmithKline, LLC. | $17.25 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116239098 | CMS |
| Lilly USA, LLC | $16.30 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135504846 | CMS |
| MERZ NORTH AMERICA, INC. | $13.49 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146378478 | CMS |
| MERZ NORTH AMERICA, INC. | $14.88 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146378476 | CMS |
| Mylan Specialty L.P. | $45.56 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147354814 | CMS |
| Novo Nordisk Inc | $19.26 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100278912 | CMS |
| Novo Nordisk Inc | $19.86 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100601261 | CMS |
| Novo Nordisk Inc | $17.29 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100253068 | CMS |
| Novo Nordisk Inc | $16.85 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100408583 | CMS |
| Novo Nordisk Inc | $16.50 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100360960 | CMS |
| Novo Nordisk Inc | $22.58 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100239626 | CMS |
| Paratek Pharmaceuticals, Inc. | $19.67 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113929864 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.